[go: up one dir, main page]

FR2809733B1 - Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants - Google Patents

Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants

Info

Publication number
FR2809733B1
FR2809733B1 FR0007113A FR0007113A FR2809733B1 FR 2809733 B1 FR2809733 B1 FR 2809733B1 FR 0007113 A FR0007113 A FR 0007113A FR 0007113 A FR0007113 A FR 0007113A FR 2809733 B1 FR2809733 B1 FR 2809733B1
Authority
FR
France
Prior art keywords
toxin
bont
detecting
determining
peptide substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0007113A
Other languages
English (en)
Other versions
FR2809733A1 (fr
Inventor
Bernard Pierre Roques
Christine Anne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR0007113A priority Critical patent/FR2809733B1/fr
Priority to US10/296,396 priority patent/US7160982B2/en
Priority to CA002409964A priority patent/CA2409964A1/fr
Priority to EP01940658A priority patent/EP1290020A1/fr
Priority to JP2002500923A priority patent/JP2003535103A/ja
Priority to PCT/FR2001/001698 priority patent/WO2001092312A1/fr
Publication of FR2809733A1 publication Critical patent/FR2809733A1/fr
Application granted granted Critical
Publication of FR2809733B1 publication Critical patent/FR2809733B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
FR0007113A 2000-06-02 2000-06-02 Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants Expired - Lifetime FR2809733B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0007113A FR2809733B1 (fr) 2000-06-02 2000-06-02 Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants
US10/296,396 US7160982B2 (en) 2000-06-02 2001-05-31 Peptide substrate identified by type BoNT/B botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors
CA002409964A CA2409964A1 (fr) 2000-06-02 2001-05-31 Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants
EP01940658A EP1290020A1 (fr) 2000-06-02 2001-05-31 Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants
JP2002500923A JP2003535103A (ja) 2000-06-02 2001-05-31 BoNT/B型のボツリヌス毒素により認識されるペプチド基質並びに前記毒素もしくは対応の阻害物質をアッセイ及び/もしくは検出する為のそれらの利用
PCT/FR2001/001698 WO2001092312A1 (fr) 2000-06-02 2001-05-31 SUBSTRAT PEPTIDIQUE RECONNU PAR LA TOXINE BOTULIQUE DE TYPE BoNT/B ET SON UTILISATION POUR DOSER ET/OU DETECTER LADITE TOXINE OU DES INHIBITEURS CORRESPONDANTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007113A FR2809733B1 (fr) 2000-06-02 2000-06-02 Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants

Publications (2)

Publication Number Publication Date
FR2809733A1 FR2809733A1 (fr) 2001-12-07
FR2809733B1 true FR2809733B1 (fr) 2004-04-30

Family

ID=8850925

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0007113A Expired - Lifetime FR2809733B1 (fr) 2000-06-02 2000-06-02 Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants

Country Status (6)

Country Link
US (1) US7160982B2 (fr)
EP (1) EP1290020A1 (fr)
JP (1) JP2003535103A (fr)
CA (1) CA2409964A1 (fr)
FR (1) FR2809733B1 (fr)
WO (1) WO2001092312A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE378596T1 (de) 2000-09-25 2007-11-15 U S Medical Res Inst Of Infect Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
FR2869908B1 (fr) * 2004-05-05 2006-07-28 Pharmaleads Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite
US7875436B2 (en) 2004-05-05 2011-01-25 Pharmaleads Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof
AU2006340711C1 (en) 2005-04-05 2013-02-07 Allergan, Inc. Clostridial toxin activity assays
ATE470857T1 (de) 2005-04-05 2010-06-15 Allergan Inc Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität
FR2931151A1 (fr) * 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
JP4864064B2 (ja) 2008-10-30 2012-01-25 エムジーファーマ株式会社 抗糖尿病作用を有するペプチドおよびその用途
US10408837B2 (en) * 2013-12-09 2019-09-10 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Peptide substrates recognizable by type E botulinum neurotoxin
EP3312290A1 (fr) * 2016-10-18 2018-04-25 Ipsen Biopharm Limited Dosage de clivage d'empeigne cellulaire

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US5962637A (en) * 1994-06-03 1999-10-05 Microbiological Research Authority Toxin assay
GB9411138D0 (en) * 1994-06-03 1994-07-27 Microbiological Res Authority Toxin assay
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins

Also Published As

Publication number Publication date
JP2003535103A (ja) 2003-11-25
CA2409964A1 (fr) 2001-12-06
FR2809733A1 (fr) 2001-12-07
EP1290020A1 (fr) 2003-03-12
WO2001092312A1 (fr) 2001-12-06
US7160982B2 (en) 2007-01-09
US20040126810A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
DZ3438A1 (fr) Inhibiteurs peptidomimetiques de protease
FR2809733B1 (fr) Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants
DZ2285A1 (fr) Inhibiteurs de protéase de la cystéine.
DE69925091D1 (de) Aktiver Pixelsensor für Farbdetektion
DE60126289D1 (de) Navigationswerkzeug
WO2008041953A3 (fr) Diagnostic et traitement de la dingue
DE60101738T2 (de) Erfassungssystem für sortiervorrichtung
DE60140561D1 (de) Steuergriff für vollwandresektionsvorrichtungen (ftrd)
DE60038403D1 (de) Abtastende Fluoreszenznachweisvorrichtung für Mehrfachproben.
DE69905048D1 (de) Optoelektronisches gerät zum nachweis von beschädigtem korn
FI982494A (fi) Kulmanilmaisumenetelmä taivutuskoneita varten, kulmanilmaisulaite ja sen kulma-anturi
DE69933807D1 (de) Peilgerät zum Verarbeiten von Messdaten
NO20006084L (no) Optisk virkende deteksjonsanordning
NO20004449D0 (no) FremgangsmÕte for Õ bestemme antibiotisk sensitivitet til bakterier
MA25758A1 (fr) Inhibiteurs de protease.
FR2869908B1 (fr) Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite
DE69927242D1 (de) Zieldetektionsanordnung
NO20032599L (no) Anordning til påvisning og lokalisering av lekkasjer
DZ2815A1 (fr) Inhibiteurs de protéase.
EP1177535A4 (fr) Procede de detection double de feuilles destine a une machine pour transaction automatique
DE60017484D1 (de) Gerät zur Erfassung von Motorumdrehungen
EP1184463A4 (fr) Procede de detection de l'interaction proteine-proteine
NO20013506D0 (no) Fremgangsmåte til bestemmelse av mikrobiell kontaminering
EP1378754A4 (fr) Capteur de detection de rotation
ATE431425T1 (de) Schnelltest der antibiotika-empfindlichkeit

Legal Events

Date Code Title Description
TQ Partial transmission of property
PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18